Starbloom Capital's book
16 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Loyal | Other Pharmaceuticals and Biotechnology | $430.0M | — | — | |
| Metamorphic (Commercial Services) | — | $235.0M | — | — | |
| Gordian Biotechnology | Drug Discovery | $170.0M | — | — | |
| Bexorg | — | $160.0M | — | — | |
| Glyphic Biotechnologies | — | $155.0M | — | — | |
| Etherealize | — | $135.0M | — | — | |
| Adaptyx | — | $41.0M | — | — | |
| Cyclarity Therapeutics | — | $34.3M | — | — | |
| Elastrin | — | $32.0M | — | — | |
| Cognito Therapeutics | — | $30.0M | — | — | |
| + 6 more companies · a free account shows the top 25 | |||||
Free account
See the whole book
- ·The book's top 25 — of 16 recorded positions
- ·Watchlist + alerts for Starbloom Capital's activity
Create free account
No card required